Fundz

ITChem raises $27.8M via convertible bonds to construct a next-gen pharmaceutical plant, with Timefolio Asset Management leading the investment.

PRIVATEFeb 23, 2026

Amount Raised

$27.8 Million

Round Type

Convertible Note

South KoreaManufacturingBiotechnologyPharmaceutical

Investors

LIFE Asset ManagementHy24Timefolio Asset Management

Description

South Korean specialty chemical company ITChem has raised approximately $27.8 million through unregistered private convertible bonds. The funds will be utilized to build a GMP-certified manufacturing facility for high-value active pharmaceutical ingredients. Major investors include Timefolio Asset Management and LIFE Asset Management, among others. The investment marks a strategic expansion for ITChem in the pharmaceutical sector.

Quick answer

ITChem raised $27.8 Million in a Convertible Note round, dated February 23, 2026. Investors: LIFE Asset Management, Hy24 and Timefolio Asset Management. ITChem is based in South Korea.

How much did ITChem raise?
ITChem raised $27.8 Million in a Convertible Note round on February 23, 2026.
Who invested in ITChem?
LIFE Asset Management, Hy24 and Timefolio Asset Management are named as investors in this round.
What does ITChem do?
ITChem is a South Korean advanced specialty chemical company focused on the production of high-value active pharmaceutical ingredients (APIs).
Where is ITChem based and how big is it?
ITChem is based in South Korea.

Source: Fundz verified event record.

Who else raised in Pharmaceutical and Manufacturing around the same time

Companies in the same sectors as ITChem that raised within 45 days of this round, from Fundz verified event records.

  • Botanix Pharmaceuticals raised $33M (Funding Round) on February 17, 2026.
  • Kaster Technologies raised $1.3M (Pre-Seed) on February 9, 2026.
  • Route 92 Medical raised $50M (Funding Round) on April 7, 2026.
  • PanTera raised $4M on March 31, 2026.
  • Neion Bio raised $11M (Seed) on March 27, 2026.
  • Elmed Life Sciences raised $2.7M (Seed) on March 26, 2026.

Who to call at ITChem, and when

A new round usually means ITChem is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ITChem raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ITChem, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ITChem. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ITChem

Location

South Korea

About

ITChem is a South Korean advanced specialty chemical company focused on the production of high-value active pharmaceutical ingredients (APIs). The company is constructing a next-generation pharmaceutical manufacturing facility that will specialize in oral small-molecule peptide therapeutics, including treatments for obesity and diabetes. ITChem's goal is to leverage its proprietary synthesis capabilities and GMP-certified infrastructure to become a global leader in organic chemical materials.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ITChem raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for ITChem's next move

See what Strategic adds

ITChem raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.